Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02012634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT05675579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07111832. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03599453. IPD Sharing: NO. Countries: 1. Publications: 0.
Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
ClinicalTrials.gov study NCT05314114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07108309. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01276899. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06382142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Triple Negative Breast Cancer and Celecoxib. Pilot Study
ClinicalTrials.gov study NCT07104266. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT05402722. IPD Sharing: YES. Countries: 1. Publications: 0.
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07371208. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07078604. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06189209. IPD Sharing: NO. Countries: 1. Publications: 0.
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
ClinicalTrials.gov study NCT06342037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05169853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
ClinicalTrials.gov study NCT05877859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer
ClinicalTrials.gov study NCT05609903. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01238952. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04676997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05677802. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.